Previous 10 | Next 10 |
2023-03-06 10:34:49 ET Picking the best cybersecurity stock to buy can be a challenging task. In this video, I aim to help with that decision by comparing CrowdStrike (NASDAQ: CRWD) and Zscaler (NASDAQ: ZS) on several critical financial metrics. *Stock prices used were...
2023-03-06 09:59:32 ET Zscaler 's (NASDAQ: ZS) explosive revenue growth is leading the company's progress toward profitability. This video will review Zscaler's Q2 2023 earnings results, and then let you know if it's an excellent time to buy the stock. *Stock prices used were ...
Stocks finished higher again on Friday, adding to gains posted the previous day. The Nasdaq led the major averages higher, surging by about 2%. Among individual stocks, C3.ai ( NYSE: AI ) represented one of the standout gainers, expanding its value by more than a third after the relea...
Zscaler ( NASDAQ: ZS ) shares fell more than 11% on Friday as the cybersecurity company reported second-quarter results that topped expectations but not as much as Wall Street had been accustomed to. For the period ending January 31, Zscaler ( ZS ) said it earned an adjust...
Shares of cybersecurity specialist Zscaler (NASDAQ: ZS) are falling today, down 10% as of 11 a.m. ET despite exceeding earnings estimates handily last night. Heading into fiscal Q2 2023, analysts had forecast a $0.29-per-share profit on sales of $364.9 million -- and the company b...
Stocks rose Friday as rates eased from their recent highs, as Wall Street aimed for a winning weekly performance. The Dow Jones Industrials raced 117.07 points to begin Friday at 33,120.64, The S&P 500 gained 33.38 points to 4,014.73. The NASDAQ Composite popped 134.87 points, or ...
Summary Zscaler, Inc.'s fiscal Q2 billings didn't live up to investors' expectations. Zscaler's customer adoption curve appears to be slowing down. Zscaler's valuation wasn't a problem when it was growing very strongly. But as it starts to ever so slightly slow down, investors are g...
Praxis Precision Medicines PRAX -49% after mid-stage data for movement disorder candidate . Veru VERU -34% after Veru COVID respiratory treatment sabizabulin declined authorization by FDA . Cidara Therapeutics ( CDTX ) -17% on launching concurrent but separa...
Despite posting fiscal second-quarter results that topped estimates, Zscaler ( NASDAQ: ZS ) shares sank more than 12% in premarket trading on Friday, prompting investment firm Wedbush Securities to defend the cybersecurity company. Analyst Dan Ives, who has an outperform ratin...
Image source: The Motley Fool. Zscaler (NASDAQ: ZS) Q2 2023 Earnings Call Mar 02, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Zscaler (ZS) Q2 2023 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
2024-07-24 11:38:05 ET USA News Group Commentary Issued on behalf of Scope AI Corp. VANCOUVER – USA News Group – The telecom market just witnessed a security breach nightmare, with the data (records of calls and texts) of nearly all customers of a giant getting stolen by...
2024-07-17 14:42:08 ET Shares of Zscaler (NASDAQ: ZS) slid 13.3% in the first six months of the year, according to data provided by S&P Global Market Intelligence . The cybersecurity stock struggled as investors came to terms with the company's slowing growth rate and increa...
2024-07-16 05:58:00 ET According to Cybersecurity Ventures, cybercrime is set to cost the world $9.5 trillion this year, and the damage bill could top $10.5 trillion in 2025. Malicious actors are even using artificial intelligence (AI) to launch highly sophisticated attacks on businesses. ...